BERGEN, NORWAY — Biomega Group, a biosciences group that develops high-quality, sustainable ingredients for the pet care industry, has appointed Silke Middendorf, Ph.D., to its chief commercial officer role. Middendorf will lead the company’s marketing and sales strategies and guide growth projects.

“We are excited to welcome Middendorf to our team and look forward to all the positive contributions she will no doubt make to our business,” said Stig Petersen, chief executive officer, Biomega. “Her track record speaks for itself, driving sales and marketing development at health and nutrition giants… We are very much a culture-driven business, and Middendorf — and her desire to make a real difference — is an ideal fit for our team in terms of our culture, values and mission. We look forward to seeing Middendorf make her mark on the long-term commercial journey of Biomega.”

Biomega new CCO Dr-Silke-MiddendorfSilke Middendorf, Ph.D., chief commercial officer at Biomega. (Source: Biomega)

With a doctorate in biophysical chemistry, Middendorf has significant experience in commercial strategy from globally operating businesses like Pfizer and Symrise.

“I am extremely pleased to join the talented Biomega team as the company’s new chief commercial officer,” Middendorf said. “The Biomega business has a strong focus on connecting life sciences and nutritional ingredients with sustainability and is offering something fresh and unique to the market. I look forward to playing my part in the international growth of the business and helping to raise the business to even greater heights.”

Read more about personnel changes throughout the industry.